Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. CBRS
3. FDX
4. USO
5. MU
6. SPY
7. KBH
8. HTZ
9. HON
10. JPM

Go back to Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results
(NASDAQ: RLMD) Delayed: 6.51 -0.26 (3.84%)
Previous Close $6.77    52 Week High $4.10 
Open $6.82    52 Week Low $0.87 
Day High $6.93    P/E N/A 
Day Low $6.50    EPS $0.00 
Volume 1,826,892